Bill

Bill > S1096


FL S1096

FL S1096
Regulation of Compounded Drug Products


summary

Introduced
11/30/2021
In Committee
12/13/2021
Crossed Over
Passed
Dead
03/14/2022

Introduced Session

2022 Regular Session

Bill Summary

Requiring the Surgeon General, on behalf of the Department of Health, to sign and become a party to the United States Food and Drug Administration's Memorandum of Understanding Addressing Certain Distributions of Compounded Human Drug Products; requiring certain pharmacy permittees to annually report information to the National Association of Boards of Pharmacy's information sharing network as required by the memorandum, etc.

AI Summary

This bill requires the Surgeon General, on behalf of the Department of Health, to sign and become a party to the United States Food and Drug Administration's (FDA) Memorandum of Understanding Addressing Certain Distributions of Compounded Human Drug Products. It also requires certain pharmacy permittees to annually report information to the National Association of Boards of Pharmacy's information sharing network as required by the memorandum, in order to enhance communication and maximize federal and state resources for the oversight of compounded drug products produced and shipped by pharmacies in Florida.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

Died in Health Policy (on 03/14/2022)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...